A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein.
A prophylactic vaccine is needed to slow the spread of HIV-1 infection. Optimization of the wild-type envelope glycoproteins to create immunogens that can elicit effective neutralizing antibodies is a high priority. Starting with ten genes encoding subtype B HIV-1 gp120 envelope glycoproteins and us...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Online Access: | http://europepmc.org/articles/PMC3126809?pdf=render |
